Guidelines: AIOM Guidelines Compilation (Italy): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Associazione Italiana di Oncologia Medica (AIOM)]]. | '''Sponsor, manager or home institution:''' [[dataOwner::Associazione Italiana di Oncologia Medica (AIOM)]]. | ||
'''Type of information:''' [[availableVariable::diagnosis]], [[availableVariable::primary | '''Type of information:''' [[availableVariable::diagnosis]], [[availableVariable::primary tumour localization]], [[availableVariable::tumour histology]], [[availableVariable::tumour staging]], [[availableVariable::comorbidities]], [[availableVariable::risk of cancer]], [[availableVariable::medical procedures]], [[availableVariable::screening]], [[availableVariable::palliative care]], [[availableVariable::year]]. | ||
'''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://www.aiom.it/linee-guida-aiom Click here to learn more]. | '''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://www.aiom.it/linee-guida-aiom Click here to learn more]. | ||
'''Access to information:''' [https://www.aiom.it/linee-guida-aiom Click here to access]. | '''Access to information:''' [https://www.aiom.it/linee-guida-aiom Click here to access]. | ||
Revision as of 00:21, 27 August 2024
Go back to Italy page
Primary purpose: To improve and standardize clinical practice, offer the best care to patients nationwide, and provide evidence-based reference for national and regional institutions, regulatory bodies, and payers, with a focus on oncology and pain therapy in cancer patients.
Sponsor, manager or home institution: Associazione Italiana di Oncologia Medica (AIOM).
Type of information: diagnosis, primary tumour localization, tumour histology, tumour staging, comorbidities, risk of cancer, medical procedures, screening, palliative care, year.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.